A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics.
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2018
Price : $35 *
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Oramed Pharmaceuticals
- 23 Oct 2018 According to an Oramed Pharmaceuticals media release, data will be presented in a poster at the 13th annual Cardio metabolic Health Congress.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 02 Jun 2015 Results will be presented at The American Diabetes Association 75th Scientific Sessions, according to an Oramed Pharmaceuticals media release.